Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma
Skin cancer is one of the most common types of cancer worldwide, and it can affect people of all ages, races, and genders. Mohs micrographic surgery (MMS), a specialized type of skin cancer surgery, boasts the highest cure rates for various types of skin malignancies. Slow Mohs surgery (SMS) is a me...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2024-05, Vol.16 (5), p.e59693-e59693 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e59693 |
---|---|
container_issue | 5 |
container_start_page | e59693 |
container_title | Curēus (Palo Alto, CA) |
container_volume | 16 |
creator | Meretsky, Christopher R Schiuma, Anthony T |
description | Skin cancer is one of the most common types of cancer worldwide, and it can affect people of all ages, races, and genders. Mohs micrographic surgery (MMS), a specialized type of skin cancer surgery, boasts the highest cure rates for various types of skin malignancies. Slow Mohs surgery (SMS) is a methodical and meticulous approach to MMS that involves careful and deliberate examination of tissue samples to ensure the complete removal of skin cancer while preserving as much healthy tissue as possible. Both SMS and MMS have been indicated to be effective treatment options for skin cancer, depending on the type and stage of cancer. This case-control study analysis compares the efficacy of SMS for melanoma with that of MMS for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). We analyzed data from the past two decades to assess recurrence rates and treatment-related complications. Our findings suggest that SMS for melanoma achieves comparable outcomes to MMS in SCC and BCC. Both approaches demonstrated similar cure rates and complication profiles. However, further prospective studies are necessary to solidify these findings and refine the specific role of SMS in melanoma therapy. |
doi_str_mv | 10.7759/cureus.59693 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11150169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3065274320</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-8005ed46bc6bc9efc6bd93ad5fec1d52f1b5c25c3ebdbf55a916eef2730c83693</originalsourceid><addsrcrecordid>eNpdkU9r3DAQxUVpaEKSW89F0EsP3XRkWbZ8KqlJ_0CWHDY9i7E83lWwrY20TtlP0K8dJZsu24BgBPPTQ-89xt4LuChLVX2xU6ApXqiqqOQbdpKJQs-00Pnbg_sxO4_xDgAElBmU8I4dS61zqLQ8YX9rP6wx4MY9EL8csd9GF7nv-KL3f_jcryJfTGFJYcvdyOfU4-gH5Di2u-Xc2eCXAdcrZw_Jxf2Eg58ir6nveY3Buv3Dbxixf7U4Y0cd9pHOX-Yp-_396rb-Obu--fGrvryeWQmwmWkARW1eNDadiro02kpiqzqyolVZJxplM2UlNW3TKYWVKIi6rJRgtUwhnbKvO9311AzUWho3AXuzDm7AsDUenfl_M7qVWfoHI4RQIJ4VPr0oBH8_UdyYwUWbzOBIybCRUKiszGUGCf34Cr3zU0ghP1Gl1LnMS5mozzsqJRljoG7_GwHmqWWza9k8t5zwD4cO9vC_TuUjef-m2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3073843473</pqid></control><display><type>article</type><title>Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma</title><source>Open Access: PubMed Central</source><source>PubMed Central Open Access</source><creator>Meretsky, Christopher R ; Schiuma, Anthony T</creator><creatorcontrib>Meretsky, Christopher R ; Schiuma, Anthony T</creatorcontrib><description>Skin cancer is one of the most common types of cancer worldwide, and it can affect people of all ages, races, and genders. Mohs micrographic surgery (MMS), a specialized type of skin cancer surgery, boasts the highest cure rates for various types of skin malignancies. Slow Mohs surgery (SMS) is a methodical and meticulous approach to MMS that involves careful and deliberate examination of tissue samples to ensure the complete removal of skin cancer while preserving as much healthy tissue as possible. Both SMS and MMS have been indicated to be effective treatment options for skin cancer, depending on the type and stage of cancer. This case-control study analysis compares the efficacy of SMS for melanoma with that of MMS for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). We analyzed data from the past two decades to assess recurrence rates and treatment-related complications. Our findings suggest that SMS for melanoma achieves comparable outcomes to MMS in SCC and BCC. Both approaches demonstrated similar cure rates and complication profiles. However, further prospective studies are necessary to solidify these findings and refine the specific role of SMS in melanoma therapy.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.59693</identifier><identifier>PMID: 38840983</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Cancer therapies ; Dermatology ; General Surgery ; Internal Medicine ; Melanoma ; Patients ; Performance evaluation ; Skin cancer ; Squamous cell carcinoma ; Statistical analysis ; Surgery ; Surgical outcomes ; Survival analysis ; Tumors ; Wound healing</subject><ispartof>Curēus (Palo Alto, CA), 2024-05, Vol.16 (5), p.e59693-e59693</ispartof><rights>Copyright © 2024, Meretsky et al.</rights><rights>Copyright © 2024, Meretsky et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2024, Meretsky et al. 2024 Meretsky et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-8005ed46bc6bc9efc6bd93ad5fec1d52f1b5c25c3ebdbf55a916eef2730c83693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150169/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150169/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38840983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meretsky, Christopher R</creatorcontrib><creatorcontrib>Schiuma, Anthony T</creatorcontrib><title>Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Skin cancer is one of the most common types of cancer worldwide, and it can affect people of all ages, races, and genders. Mohs micrographic surgery (MMS), a specialized type of skin cancer surgery, boasts the highest cure rates for various types of skin malignancies. Slow Mohs surgery (SMS) is a methodical and meticulous approach to MMS that involves careful and deliberate examination of tissue samples to ensure the complete removal of skin cancer while preserving as much healthy tissue as possible. Both SMS and MMS have been indicated to be effective treatment options for skin cancer, depending on the type and stage of cancer. This case-control study analysis compares the efficacy of SMS for melanoma with that of MMS for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). We analyzed data from the past two decades to assess recurrence rates and treatment-related complications. Our findings suggest that SMS for melanoma achieves comparable outcomes to MMS in SCC and BCC. Both approaches demonstrated similar cure rates and complication profiles. However, further prospective studies are necessary to solidify these findings and refine the specific role of SMS in melanoma therapy.</description><subject>Cancer therapies</subject><subject>Dermatology</subject><subject>General Surgery</subject><subject>Internal Medicine</subject><subject>Melanoma</subject><subject>Patients</subject><subject>Performance evaluation</subject><subject>Skin cancer</subject><subject>Squamous cell carcinoma</subject><subject>Statistical analysis</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Survival analysis</subject><subject>Tumors</subject><subject>Wound healing</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkU9r3DAQxUVpaEKSW89F0EsP3XRkWbZ8KqlJ_0CWHDY9i7E83lWwrY20TtlP0K8dJZsu24BgBPPTQ-89xt4LuChLVX2xU6ApXqiqqOQbdpKJQs-00Pnbg_sxO4_xDgAElBmU8I4dS61zqLQ8YX9rP6wx4MY9EL8csd9GF7nv-KL3f_jcryJfTGFJYcvdyOfU4-gH5Di2u-Xc2eCXAdcrZw_Jxf2Eg58ir6nveY3Buv3Dbxixf7U4Y0cd9pHOX-Yp-_396rb-Obu--fGrvryeWQmwmWkARW1eNDadiro02kpiqzqyolVZJxplM2UlNW3TKYWVKIi6rJRgtUwhnbKvO9311AzUWho3AXuzDm7AsDUenfl_M7qVWfoHI4RQIJ4VPr0oBH8_UdyYwUWbzOBIybCRUKiszGUGCf34Cr3zU0ghP1Gl1LnMS5mozzsqJRljoG7_GwHmqWWza9k8t5zwD4cO9vC_TuUjef-m2w</recordid><startdate>20240505</startdate><enddate>20240505</enddate><creator>Meretsky, Christopher R</creator><creator>Schiuma, Anthony T</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240505</creationdate><title>Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma</title><author>Meretsky, Christopher R ; Schiuma, Anthony T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-8005ed46bc6bc9efc6bd93ad5fec1d52f1b5c25c3ebdbf55a916eef2730c83693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cancer therapies</topic><topic>Dermatology</topic><topic>General Surgery</topic><topic>Internal Medicine</topic><topic>Melanoma</topic><topic>Patients</topic><topic>Performance evaluation</topic><topic>Skin cancer</topic><topic>Squamous cell carcinoma</topic><topic>Statistical analysis</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Survival analysis</topic><topic>Tumors</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meretsky, Christopher R</creatorcontrib><creatorcontrib>Schiuma, Anthony T</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meretsky, Christopher R</au><au>Schiuma, Anthony T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-05-05</date><risdate>2024</risdate><volume>16</volume><issue>5</issue><spage>e59693</spage><epage>e59693</epage><pages>e59693-e59693</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Skin cancer is one of the most common types of cancer worldwide, and it can affect people of all ages, races, and genders. Mohs micrographic surgery (MMS), a specialized type of skin cancer surgery, boasts the highest cure rates for various types of skin malignancies. Slow Mohs surgery (SMS) is a methodical and meticulous approach to MMS that involves careful and deliberate examination of tissue samples to ensure the complete removal of skin cancer while preserving as much healthy tissue as possible. Both SMS and MMS have been indicated to be effective treatment options for skin cancer, depending on the type and stage of cancer. This case-control study analysis compares the efficacy of SMS for melanoma with that of MMS for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). We analyzed data from the past two decades to assess recurrence rates and treatment-related complications. Our findings suggest that SMS for melanoma achieves comparable outcomes to MMS in SCC and BCC. Both approaches demonstrated similar cure rates and complication profiles. However, further prospective studies are necessary to solidify these findings and refine the specific role of SMS in melanoma therapy.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38840983</pmid><doi>10.7759/cureus.59693</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Curēus (Palo Alto, CA), 2024-05, Vol.16 (5), p.e59693-e59693 |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11150169 |
source | Open Access: PubMed Central; PubMed Central Open Access |
subjects | Cancer therapies Dermatology General Surgery Internal Medicine Melanoma Patients Performance evaluation Skin cancer Squamous cell carcinoma Statistical analysis Surgery Surgical outcomes Survival analysis Tumors Wound healing |
title | Comparative Analysis of Slow Mohs Surgery in Melanoma and Mohs Micrographic Surgery in Squamous Cell Carcinoma and Basal Cell Carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Analysis%20of%20Slow%20Mohs%20Surgery%20in%20Melanoma%20and%20Mohs%20Micrographic%20Surgery%20in%20Squamous%20Cell%20Carcinoma%20and%20Basal%20Cell%20Carcinoma&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Meretsky,%20Christopher%20R&rft.date=2024-05-05&rft.volume=16&rft.issue=5&rft.spage=e59693&rft.epage=e59693&rft.pages=e59693-e59693&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.59693&rft_dat=%3Cproquest_pubme%3E3065274320%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3073843473&rft_id=info:pmid/38840983&rfr_iscdi=true |